RK
Raj Khurana
About Raj Khurana
Data last updated:
Raj Khurana is a Director at Eswar Therapeutics Private Limited (since 2023) and Director at Elinza Pharmaceuticals Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹54.20 Cr; the largest is Eswar Therapeutics Private Limited at ₹54.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eswar Therapeutics Private Limited U24304CH2017PTC041467 | Director | 01 Apr 2023 | 2017 | ₹54.06 Cr (FY 2025) | Active |
 Elinza Pharmaceuticals Private Limited U51909CH2022PTC044296 | Director | 25 Nov 2024 | 2022 | ₹14.4 Lakh (FY 2025) | Active |
Board colleagues of Raj Khurana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kashmiri Lal Khunger | 10391173 | Eswar Therapeutics Private Limited | Director |
| Vikram Khungar | 06867915 | Eswar Therapeutics Private Limited , Elinza Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raj Khurana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raj Khurana
Raj Khurana currently holds 2 directorships: Eswar Therapeutics Private Limited (Director, since 01 Apr 2023, revenue ₹54.06 Cr (FY 2025)); Elinza Pharmaceuticals Private Limited (Director, since 25 Nov 2024, revenue ₹14.4 Lakh (FY 2025)).
Raj Khurana was first appointed on 01 Apr 2023 as Director at Eswar Therapeutics Private Limited. The most recent appointment on record is 25 Nov 2024 at Elinza Pharmaceuticals Private Limited.
The 2 current companies of Raj Khurana that report revenue have a combined latest revenue of ₹54.20 Cr: Eswar Therapeutics Private Limited ₹54.06 Cr (FY 2025); Elinza Pharmaceuticals Private Limited ₹14.4 Lakh (FY 2025).
The current boards of Raj Khurana's companies include Kashmiri Lal Khunger (Eswar Therapeutics Private Limited), Vikram Khungar (Eswar Therapeutics Private Limited).